DrugPatentWatch Database Preview
SOLOSEC Drug Profile
When do Solosec patents expire, and when can generic versions of Solosec launch?
Solosec is a drug marketed by Lupin and is included in one NDA.
The generic ingredient in SOLOSEC is secnidazole. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the secnidazole profile page.
Summary for SOLOSEC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 70 |
| Patent Applications: | 246 |
| Drug Prices: | Drug price information for SOLOSEC |
| DailyMed Link: | SOLOSEC at DailyMed |
Generic Entry Opportunity Date for SOLOSEC
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for SOLOSEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Lupin | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
